SCHEMBL341554

SCHEMBL341554

Cc1cc(C)c(S(=O)(=O)[O-])c(C)c1Nc1ccc(Nc2c(C)cc(C)c(S(=O)(=O)[O-])c2C)c2c1C(=O)c1ccccc1C2=O.[Na+].[Na+]

nearest known ligand 0.55

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 known ✓ P47900 3/20 0.55
THRB known ✓ P10828 2/20 0.55
P2RY4 known ✓ P51582 11/20 0.48
P2RY2 known ✓ P41231 8/20 0.48
P2RY12 known ✓ Q9H244 6/20 0.46
P2RY6 known ✓ Q15077 2/20 0.43
MEN1 O00255 2/20 0.55
NSD2 O96028 2/20 0.55
ALDH1A1 P00352 2/20 0.55
POLB P06746 2/20 0.55
MAPT P10636 2/20 0.55
HPGD P15428 2/20 0.55
MAPK1 P28482 2/20 0.55
RECQL P46063 2/20 0.55
KMT2A Q03164 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
NPSR1 Q6W5P4 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
MET P08581 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29356228 1.00 P2RY1 (0.55) P2RY1MEN1NSD2ALDH1A1POLB
SCHEMBL30887179 0.86 MEN1 (0.46) P2RY1MEN1NSD2ALDH1A1POLB
SCHEMBL7740603 0.86 MEN1 (0.46) P2RY1MEN1NSD2ALDH1A1POLB
SCHEMBL8947711 0.86 MAPK1 (0.46) P2RY1MEN1NSD2ALDH1A1POLB
SCHEMBL15452097 0.84 CXCR2 (0.46) P2RY1MEN1NSD2ALDH1A1POLB
SCHEMBL11932628 0.82 MAPT (0.43) P2RY1MEN1NSD2ALDH1A1POLB
SCHEMBL13316757 0.82 MAPT (0.48) P2RY1MEN1NSD2ALDH1A1POLB
SCHEMBL20043780 0.81 MAPK1 (0.42) P2RY1MEN1NSD2ALDH1A1POLB
SCHEMBL15448839 0.81 SMN1; SMN2 (0.44) P2RY1MEN1NSD2ALDH1A1POLB
SCHEMBL25851919 0.81 MAPK1 (0.53) P2RY1MEN1NSD2ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2826540-B1 Activated carbon based composition to sequester flue gas mercury in concrete ALBEMARLE CORP (US) 2018-05-09 EP claimed
EP-2688658-B1 METHOD TO SEQUESTER FLUE GAS MERCURY IN CONCRETE ALBEMARLE CORP (US) 2016-10-12 EP claimed
EP-2099550-B1 METHOD TO SEQUESTER FLUE GAS MERCURY IN CONCRETE ALBEMARLE CORP (US) 2014-11-19 EP claimed
EP-4416254-A1 COMPOSITION Paui AB (SE) 2024-08-21 EP disclosed
CN-116657416-B Environment-friendly dyeing process for cotton and linen textile 宁波泓萌新材料科技有限公司 2024-08-20 CN disclosed
CN-116657416-A Environment-friendly dyeing process for cotton and linen textile 昆明成先酞纺织有限公司 2023-08-29 CN disclosed
WO-2023063867-A1 COMPOSITION PAUI AB (SE) 2023-04-20 WO disclosed
EP-2710996-B1 Sunscreen compositions comprising colour pigments BASF SE (DE) 2022-08-17 EP disclosed
US-11384033-B2 Compositions with improved urease-inhibiting effect comprising (thio)phosphoric acid triamide and further compounds such as amines and colorants BASF SE (DE) 2022-07-12 US disclosed
US-20210115489-A1 NOVEL MEDIATOR KIKKOMAN CORPORATION (JP) 2021-04-22 US disclosed
CN-112522148-A Method for culturing high-performance composite flora by using printing and dyeing wastewater 江南大学 2021-03-19 CN disclosed
CN-1842319-A Dye composition and method for examining tooth demineralization damage PROCTER & GAMBLE (US) 2006-10-04 CN disclosed
WO-2005087908-A1 BLEACH ACTIVATORS AND METHOD FOR THE PRODUCTION THEREOF HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2005-09-22 WO disclosed
US-20050197634-A1 Methods for coating and impregnating medical devices with antiseptic compositions BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2005-09-08 US disclosed
US-20050058602-A1 Dye composition and method for detection of demineralized lesions in teeth THE PROCTER & GAMBLE COMPANY 2005-03-17 US disclosed
WO-2003089559-A1 BLUE COLORED LIQUID CRYSTAL COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2003-10-30 WO disclosed
US-6475975-B1 Blue colored liquid crystal compositions COLGATE-PALMOLIVE COMPANY 2002-11-05 US disclosed
US-5385842-A Anthraquinones as inhibitors of sulfide production from sulfate-reducing bacteria E. I. DU PONT DE NEMOURS AND COMPANY (US) 1995-01-31 US disclosed
EP-0525073-A1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. DU PONT (US) 1993-02-03 EP disclosed
WO-1991015954-A1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-10-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115489-A1 NOVEL MEDIATOR MPO, EPX, LPO P2RY1 2661/4885THRB 4364/4885P2RY4 1946/4885
US-11384033-B2 Compositions with improved urease-inhibiting effect comprising (thio)phosphoric acid triamide and further compounds such as amines and colorants SLC14A1, XDH, PNP P2RY1 701/4885THRB 972/4885P2RY4 1162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.